What is the importance of ALK fusion mutations? What are the therapeutic implications of detection? How effective are second-generation ALK inhibitors? What does the data show as far as PFS?

What is the importance of ALK fusion mutations? What are the therapeutic implications of detection? How effective are second-generation ALK inhibitors? What does the data show as far as PFS?

What is the importance of ALK fusion mutations? What are the therapeutic implications of their detection? How effective are the second-generation ALK inhibitors? What does the data show as far as PFS?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor James CH Yang, MD, PhD

Professor James CH Yang, MD, PhD

Professor, Graduate Institute of Oncology
National Taiwan University
Director, Department of Oncology
National Taiwan University Hospital
Taipei, Taiwan